Skip to main content
. 2024 Apr 19;47(7):918–928. doi: 10.1007/s00270-024-03718-9

Table 2.

Outcome measures between the three groups

Non-BGC (n = 118) BGC without inflated balloon (n = 210) BGC with inflated balloon (n = 100)
mRS at 90 days#n (%)
0 5 (4.7) 12 (5.9) 2 (2.2)
1 16 (15) 26 (13) 11 (12)
2 23 (22) 35 (17) 20 (22)
3 13 (12) 37 (18) 13 (14)
4 13 (12) 17 (8.4) 7 (7.7)
5 4 (3.8) 18 (8.9) 7 (7.7)
6 32 (30) 57 (28) 31 (34)
mRS score 0–1#n (%) 21 (20) 38 (19) 13 (14)
mRS score 0–2#n (%) 44 (42) 73 (36) 33 (36)
Successful reperfusion (eTICI ≥ 2B)—n (%) 105 (89) 188 (90) 91 (91)
Excellent reperfusion (eTICI ≥ 2C)—n (%) 87 (74) 149 (71) 73 (73)
Complete reperfusion (eTICI = 3)—n (%) 43 (36) 55 (26) 46 (46)
Mortality at 90 days—n (%) 32 (30) 57 (28) 31 (34)
NIHSS post intervention^—median [IQR] 7 [2.0–17] 9 [4.0–16] 10 [2.5–17]
NIHSS ≥ 4 improvement^n (%) 60 (56) 94 (50) 44 (51)
Procedure time –median minutes [IQR] 26.5 [15–45] 30.0 [16–45] 25.0 [15–46]
Total attempts—median [IQR] 2 [1–3] 1 [1–3] 1 [1–3]
First-attempt successful (2C-3)—n (%) 41 (35) 89 (42) 47 (47)
Periprocedural complications—n (%) 16 (14) 45 (21) 25 (25)

#mRS was missing in 29 patients; ^ NIHSS was missing in 38 patients

BGC balloon guide catheter, mRS modified Rankin scale, eTICI expanded treatment in cerebral ischemia, NIHSS National Institutes of Health Stroke Scale, IQR interquartile range